ID

44663

Descrizione

Alendronate to Prevent Loss of Bronchoprotection in Asthma; ODM derived from: https://clinicaltrials.gov/show/NCT02230332

collegamento

https://clinicaltrials.gov/show/NCT02230332

Keywords

  1. 10/04/16 10/04/16 -
  2. 27/09/21 27/09/21 -
Caricato su

27 settembre 2021

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0

Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Asthma NCT02230332

Eligibility Asthma NCT02230332

  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT02230332
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
clinical history consistent with moderate asthma for >1 year
Descrizione

Moderate persistent asthma

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1960047
asthma is controlled with ics, with an fp dose ≤ 1000mcg/day and >100mcg/day (or equivalent)
Descrizione

Asthma | inhaled steroids | Fluticasone propionate

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0004096
UMLS CUI [2]
C2065041
UMLS CUI [3]
C0117996
able to perform reproducible spirometry according to ats criteria
Descrizione

Ability Spirometry

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0085732
UMLS CUI [1,2]
C0037981
baseline fev1 ≥ 50% of predicted and ≥1l.
Descrizione

FEV1

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0748133
if fev1 <80%, a minimum 12% increase in fev1 post-bronchodilator or a mch pc20 ≤ 8 mg/ml
Descrizione

FEV1 post bronchodilator | Methacholine

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0748133
UMLS CUI [1,2]
C2599594
UMLS CUI [2]
C0600370
if fev1 ≥80%, a mch pc20 ≤ 8 mg/ml
Descrizione

FEV1 | Methacholine

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0748133
UMLS CUI [2]
C0600370
salmeterol protected mch ≤ 16 mg/ml
Descrizione

salmeterol | Methacholine

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0073992
UMLS CUI [2]
C0600370
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
uncontrolled asthma, as suggested by an act score <18 while on high-dose ics (fp daily dose >500mcg or equivalent)
Descrizione

Asthma Uncontrolled | Asthma control test score | inhaled steroids | Fluticasone propionate

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0004096
UMLS CUI [1,2]
C0205318
UMLS CUI [2]
C2733224
UMLS CUI [3]
C2065041
UMLS CUI [4]
C0117996
non-ics controller medication or laba use within 4 weeks of study entry.
Descrizione

inhaled steroids | Adrenergic beta-2 Receptor Agonists

Tipo di dati

boolean

Alias
UMLS CUI [1]
C2065041
UMLS CUI [2]
C2936789
contraindications to use of bisphosphonates: history of intolerance to bisphosphonates, history of esophageal ulcers, history of hematemesis, uncontrolled gastro-esophageal reflux disease, inability to stay erect for 30 minutes after oral drug, history of osteonecrosis of the jaw, dental extraction or root canal in prior 8 weeks, or anticipated during the study
Descrizione

contraindications Diphosphonates | intolerance to substance Diphosphonates | Ulcer of esophagus | Hematemesis | Gastroesophageal reflux disease Uncontrolled | Oral drug preparation | Aseptic necrosis of bone of jaw | Tooth Extraction | Root Canal Therapy

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0079164
UMLS CUI [1,2]
C0012544
UMLS CUI [2,1]
C1744706
UMLS CUI [2,2]
C0012544
UMLS CUI [3]
C0151970
UMLS CUI [4]
C0018926
UMLS CUI [5,1]
C0017168
UMLS CUI [5,2]
C0205318
UMLS CUI [6]
C0304289
UMLS CUI [7]
C2711248
UMLS CUI [8]
C0040440
UMLS CUI [9]
C0035849
calculated gfr of less than 35 ml/min
Descrizione

Glomerular Filtration Rate Calculated (procedure)

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0017654
UMLS CUI [1,2]
C0444686
history of smoking (cigarettes, cigars, pipes, marijuana or any other substances) within the past 1 year, or > 10 pack-years total if ≥ 18 years of age
Descrizione

Smoking History | Cigarette | Cigars | smoking pipe | Marihuana | smoking cigarettes: ____ pack-years history | Age

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1519384
UMLS CUI [2]
C0677453
UMLS CUI [3]
C0678446
UMLS CUI [4]
C0240766
UMLS CUI [5]
C0024808
UMLS CUI [6]
C2230126
UMLS CUI [7]
C0001779
systemic corticosteroid treatment for any condition within 4 weeks of enrollment at visit 1, history of significant asthma exacerbation requiring systemic corticosteroids within 4 weeks of visit 1 or more than five courses of systemic corticosteroids in the past year, history of a life-threatening asthma exacerbation requiring intubation, mechanical ventilation, or resulting in a hypoxic seizure within the last 2 years
Descrizione

Exacerbation of asthma | Therapeutic procedure systemic steroids | Exacerbation of asthma Life Threatening | Intubation | Mechanical ventilation | Hypoxic convulsions

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0349790
UMLS CUI [2,1]
C0087111
UMLS CUI [2,2]
C2825233
UMLS CUI [3,1]
C0349790
UMLS CUI [3,2]
C2826244
UMLS CUI [4]
C0021925
UMLS CUI [5]
C0199470
UMLS CUI [6]
C1843573
history of a respiratory tract infection within 4 weeks of visit 1
Descrizione

Respiratory Tract Infections

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0035243
receiving hyposensitization therapy other than an established maintenance regimen defined as a continuous regimen for ≥ 3 months prior to enrollment
Descrizione

hypersensitivity desensitization Continuous

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0178702
UMLS CUI [1,2]
C0549178

Similar models

Eligibility Asthma NCT02230332

  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT02230332
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Moderate persistent asthma
Item
clinical history consistent with moderate asthma for >1 year
boolean
C1960047 (UMLS CUI [1])
Asthma | inhaled steroids | Fluticasone propionate
Item
asthma is controlled with ics, with an fp dose ≤ 1000mcg/day and >100mcg/day (or equivalent)
boolean
C0004096 (UMLS CUI [1])
C2065041 (UMLS CUI [2])
C0117996 (UMLS CUI [3])
Ability Spirometry
Item
able to perform reproducible spirometry according to ats criteria
boolean
C0085732 (UMLS CUI [1,1])
C0037981 (UMLS CUI [1,2])
FEV1
Item
baseline fev1 ≥ 50% of predicted and ≥1l.
boolean
C0748133 (UMLS CUI [1])
FEV1 post bronchodilator | Methacholine
Item
if fev1 <80%, a minimum 12% increase in fev1 post-bronchodilator or a mch pc20 ≤ 8 mg/ml
boolean
C0748133 (UMLS CUI [1,1])
C2599594 (UMLS CUI [1,2])
C0600370 (UMLS CUI [2])
FEV1 | Methacholine
Item
if fev1 ≥80%, a mch pc20 ≤ 8 mg/ml
boolean
C0748133 (UMLS CUI [1])
C0600370 (UMLS CUI [2])
salmeterol | Methacholine
Item
salmeterol protected mch ≤ 16 mg/ml
boolean
C0073992 (UMLS CUI [1])
C0600370 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Asthma Uncontrolled | Asthma control test score | inhaled steroids | Fluticasone propionate
Item
uncontrolled asthma, as suggested by an act score <18 while on high-dose ics (fp daily dose >500mcg or equivalent)
boolean
C0004096 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C2733224 (UMLS CUI [2])
C2065041 (UMLS CUI [3])
C0117996 (UMLS CUI [4])
inhaled steroids | Adrenergic beta-2 Receptor Agonists
Item
non-ics controller medication or laba use within 4 weeks of study entry.
boolean
C2065041 (UMLS CUI [1])
C2936789 (UMLS CUI [2])
contraindications Diphosphonates | intolerance to substance Diphosphonates | Ulcer of esophagus | Hematemesis | Gastroesophageal reflux disease Uncontrolled | Oral drug preparation | Aseptic necrosis of bone of jaw | Tooth Extraction | Root Canal Therapy
Item
contraindications to use of bisphosphonates: history of intolerance to bisphosphonates, history of esophageal ulcers, history of hematemesis, uncontrolled gastro-esophageal reflux disease, inability to stay erect for 30 minutes after oral drug, history of osteonecrosis of the jaw, dental extraction or root canal in prior 8 weeks, or anticipated during the study
boolean
C0079164 (UMLS CUI [1,1])
C0012544 (UMLS CUI [1,2])
C1744706 (UMLS CUI [2,1])
C0012544 (UMLS CUI [2,2])
C0151970 (UMLS CUI [3])
C0018926 (UMLS CUI [4])
C0017168 (UMLS CUI [5,1])
C0205318 (UMLS CUI [5,2])
C0304289 (UMLS CUI [6])
C2711248 (UMLS CUI [7])
C0040440 (UMLS CUI [8])
C0035849 (UMLS CUI [9])
Glomerular Filtration Rate Calculated (procedure)
Item
calculated gfr of less than 35 ml/min
boolean
C0017654 (UMLS CUI [1,1])
C0444686 (UMLS CUI [1,2])
Smoking History | Cigarette | Cigars | smoking pipe | Marihuana | smoking cigarettes: ____ pack-years history | Age
Item
history of smoking (cigarettes, cigars, pipes, marijuana or any other substances) within the past 1 year, or > 10 pack-years total if ≥ 18 years of age
boolean
C1519384 (UMLS CUI [1])
C0677453 (UMLS CUI [2])
C0678446 (UMLS CUI [3])
C0240766 (UMLS CUI [4])
C0024808 (UMLS CUI [5])
C2230126 (UMLS CUI [6])
C0001779 (UMLS CUI [7])
Exacerbation of asthma | Therapeutic procedure systemic steroids | Exacerbation of asthma Life Threatening | Intubation | Mechanical ventilation | Hypoxic convulsions
Item
systemic corticosteroid treatment for any condition within 4 weeks of enrollment at visit 1, history of significant asthma exacerbation requiring systemic corticosteroids within 4 weeks of visit 1 or more than five courses of systemic corticosteroids in the past year, history of a life-threatening asthma exacerbation requiring intubation, mechanical ventilation, or resulting in a hypoxic seizure within the last 2 years
boolean
C0349790 (UMLS CUI [1])
C0087111 (UMLS CUI [2,1])
C2825233 (UMLS CUI [2,2])
C0349790 (UMLS CUI [3,1])
C2826244 (UMLS CUI [3,2])
C0021925 (UMLS CUI [4])
C0199470 (UMLS CUI [5])
C1843573 (UMLS CUI [6])
Respiratory Tract Infections
Item
history of a respiratory tract infection within 4 weeks of visit 1
boolean
C0035243 (UMLS CUI [1])
hypersensitivity desensitization Continuous
Item
receiving hyposensitization therapy other than an established maintenance regimen defined as a continuous regimen for ≥ 3 months prior to enrollment
boolean
C0178702 (UMLS CUI [1,1])
C0549178 (UMLS CUI [1,2])

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial